A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL).
Clinical trial NCT01021423 · TERMINATED
Trial details
- NCT number
- NCT01021423
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.